The mechanism by which elevated CD47 expression leads to improved survival in these cancers is unknown, but it is not consistent with the ‘don’t eat me’ hypothesis, which predicts poorer survival due to decreased innate immune clearance of tumor cells bearing high CD47. This evidence concerns the gene CD47 and cancer.